- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Chronic Spontaneous Urticaria
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
Article
Canada OKs Cutera's Excel V laser system
Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.
Brisbane, Calif. - Cutera has announced that Canadian regulatory agency Health Canada has approved the company’s Excel V laser for vascular, pigment and overall skin-rejuvenation treatments, Globe Newswire reports.
The Excel V system features a dual wavelength platform. One handpiece includes a 532 nm laser for superficial vessels and pigments, and a 1,064 nm Nd:YAG laser to treat leg veins, port wine stains and hemangiomas. The second handpiece, for facial rejuvenation, affords a collagen-producing solution for fine lines, uneven texture and premature aging.
The Excel V also features ergonomic handpieces, a solid-state design and a sapphire window with real-time calibration and spot size adjustment, enabling the precise targeting of lesions, the company states.
Go back to the Dermatology Times eNews newsletter.
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
